Total knee arthroplasty
DeviceMobile Bearing Total knee Arthroplasty
Other names: Sigma® RP-F Knee System, Depuy J&J, Warsaw, IN, USA
NCT Number: NCT01751334
The anatomic landmark for the anteroposterior (AP) axis of the proximal tibia and its variability was investigated in this study in order to determine whether a certain landmark could be employed as a reference axis for the proximal tibia after rotating platform mobile bearing (RP-MB) and fixed bearing (FB) total knee arthroplasties (TKAs).
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 4
Reference of tibial AP axis for implanting tibial component in total knee arthroplasty have not been concluded. This study can suggest appropriate method for alingning the tibial component to accurate tibial AP axis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mobile Bearing Total knee Arthroplasty
Other names: Sigma® RP-F Knee System, Depuy J&J, Warsaw, IN, USA
Time frame: postoperative 2 weeks
Tibial anteroposterior axis relative to femoral anteroposterior axis on Computed tomogram images
Seoul National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07660081
Arthritis, Body Weight
Bannu, KPK, Pakistan
View Trial DetailsNCT04637529
Agnosia, Arthritis
São Paulo, Brazil
View Trial DetailsNCT03226808
Arthritis, Avascular Necrosis of Bone of Hip
Parker, Colorado, United States
View Trial DetailsNCT04544904
Arthritis, Behavior
London, Ontario, Canada
View Trial Details